| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.27 | 1e-06 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.22 | 5e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.23 | 0.0002 |